Skip to main content

Table 1 Efficacy of oral moxidectin against ML-resistant heartworms compared to Heartgard® Plus or Interceptor® Plus: study designs

From: Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs

Group

Treatment

Oral dosage

No. of dogs

Day of L3D. immitis inoculationa

Days of treatment

Days of blood microfilariae and adult D. immitis antigen testingb

Day of necropsy and adult D. immitis worm recovery

T01

Negative control

na

6

-30

0, 30, 60, 90, 120, 150

-36 or -30, 60, 180, 210, 236 or 243

237 or 243

T02

Moxidectin

24 µg/kg

6

-30

0, 30, 60, 90

T03

Moxidectin

24 µg/kg

6

-30

0, 30, 60, 90, 120, 150

T04

Heartgard® Plus

Min. of 6 µg/kgc

6

-30

0, 30, 60, 90, 120, 150

T05

Interceptor® Plus

Min. of 500 µg/kgc

6

-30

0, 30, 60, 90, 120, 150

  1. aEach dog was inoculated with 50 infective L3 of D. immitis of either ZoeLA (Study 1) or JYD-34 (Study 2)
  2. bDay 180 testing only conducted in Study 2
  3. cHeartgard® Plus and Interceptor® Plus administered at their approved dosages according to their commercial label directions